Immunic (IMUX) Goodwill (2019 - 2022)

Immunic has disclosed Goodwill across 4 years of filings, most recently posting $33.0 million for Q3 2022.

• Goodwill for Q3 2022 came in at $33.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2022 was $33.0 million (changed 0.0% YoY), and the FY2021 annual result was $33.0 million, changed 0.0% from the prior year.
• Goodwill came in at $33.0 million for Q3 2022 at Immunic, roughly flat from $33.0 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $33.0 million in Q2 2019 to a low of $33.0 million in Q2 2019.
• The 4-year median for Goodwill is $33.0 million (2019), against an average of $33.0 million.
• Peak annual rise in Goodwill reached 0.0% in 2020, while the deepest fall reached 0.0% in 2020.
• Immunic's Goodwill stood at $33.0 million in 2019, then changed by 0.0% to $33.0 million in 2020, then changed by 0.0% to $33.0 million in 2021, then changed by 0.0% to $33.0 million in 2022.
• The last three Goodwill figures came in at $33.0 million (Q3 2022), $33.0 million (Q2 2022), and $33.0 million (Q1 2022), per Business Quant data.